Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline (Q36471058)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16680409

retrieved

14 August 2017

review article

1 reference

stated in

Europe PubMed Central

title

Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16680409

retrieved

14 August 2017

main subject

systematic review

1 reference

based on heuristic

inferred from title

author

Stephen Faraone

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16680409

retrieved

14 August 2017

Tobias Banaschewski

series ordinal

1

object named as

Tobias Banaschewski

0 references

Hans-Christoph Steinhausen

series ordinal

12

object named as

Hans-Christoph Steinhausen

0 references

Aribert Rothenberger

series ordinal

10

object named as

Aribert Rothenberger

0 references

David Coghill

series ordinal

2

0 references

Philip Asherson

object named as

Philip Asherson

series ordinal

5

0 references

Jan Buitelaar

series ordinal

6

object named as

Jan Buitelaar

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16680409

retrieved

14 August 2017

Edmund Sonuga-Barke

series ordinal

13

object named as

Edmund J S Sonuga-Barke

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16680409

retrieved

14 August 2017

Paramala J Santosh

series ordinal

3

object named as

Paramala Santosh

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16680409

retrieved

14 August 2017

Alessandro Zuddas

series ordinal

4

object named as

Alessandro Zuddas

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16680409

retrieved

14 August 2017

Marina Danckaerts

series ordinal

7

object named as

Marina Danckaerts

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16680409

retrieved

14 August 2017

Manfred Döpfner

series ordinal

8

object named as

Manfred Döpfner

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16680409

retrieved

14 August 2017

author name string

Joseph Sergeant

series ordinal

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16680409

retrieved

14 August 2017

Eric Taylor

series ordinal

14

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16680409

retrieved

14 August 2017

publication date

5 May 2006

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16680409

retrieved

14 August 2017

published in

European Child & Adolescent Psychiatry

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16680409

retrieved

14 August 2017

volume

15

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16680409

retrieved

14 August 2017

issue

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16680409

retrieved

14 August 2017

page(s)

476-495

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16680409

retrieved

14 August 2017

cites work

Treatment of ADHD in children with tics: a randomized controlled trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS00787-006-0549-0

retrieved

21 January 2018

Comparing the efficacy of medications for ADHD using meta-analysis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Attention-deficit/hyperactivity disorder in adults: an overview

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Obsessive compulsive disorder

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural outcome of ADHD with developmental coordination disorder at age 22 years: a controlled, longitudinal, community-based study.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of Ritalin LA, a new, once daily, extended-release dosage form of methylphenidate, in children with attention deficit hyperactivity disorder

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: preliminary indications from a secondary analysis of the COMACS study data

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Young adult follow-up of hyperactive children: self-reported psychiatric disorders, comorbidity, and the role of childhood conduct problems and teen CD.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of SLI381 (ADDERALL XR), an extended-release formulation of Adderall

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacotherapies for attention-deficit/hyperactivity disorder: expected-cost analysis.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonmedical use of prescription opioids among U.S. college students: prevalence and correlates from a national survey.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychopharmacology and aggression. I: A meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methylphenidate bioavailability from two extended-release formulations

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopamine in drug abuse and addiction: results from imaging studies and treatment implications

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, mul

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and Clinical Effectiveness of Methylphenidate

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvement in health-related quality of life in children with ADHD: an analysis of placebo controlled studies of atomoxetine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does a morning dose of Methylphenidate Retard reduce hyperkinetic symptoms in the afternoon?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does the medicating ADHD increase or decrease the risk for later substance abuse?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychometric validation of the child health questionnaire (CHQ) in a sample of children and adolescents with attention-deficit/hyperactivity disorder

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative efficacy of two once daily methylphenidate formulations (Ritalin LA and Concerta) and placebo in children with attention deficit hyperactivity disorder across the school day.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Emergence of tics in children with ADHD: impact of once-daily OROS methylphenidate therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the clinical efficacy of twice-daily Ritalin and once-daily Equasym XL with placebo in children with Attention Deficit/Hyperactivity Disorder

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The measurement of health-related quality of life (QOL) in paediatric clinical trials: a systematic review

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ADHD treatment with once-daily OROS methylphenidate: final results from a long-term open-label study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHD.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of stimulants in the treatment of preschool children with attention-deficit hyperactivity disorder

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depressive disorders

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of methylphenidate formulation for attention deficit hyperactivity disorder on patterns and outcomes of treatment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term, open-label study of the safety and efficacy of atomoxetine in adults with attention-deficit/hyperactivity disorder: an interim analysis.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atomoxetine: a review of its use in adults with attention deficit hyperactivity disorder

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of atomoxetine in childhood attention-deficit/hyperactivity disorder with comorbid oppositional defiant disorder

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European clinical guidelines for hyperkinetic disorder -- first upgrade

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Varieties of preschool hyperactivity: multiple pathways from risk to disorder

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative efficacy of once-a-day extended-release methylphenidate, two-times-daily immediate-release methylphenidate, and placebo in a laboratory school setting

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16680409

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S00787-006-0549-0

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16680409

retrieved

14 August 2017

PubMed publication ID

16680409

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16680409

retrieved

14 August 2017

ResearchGate publication ID

7101511

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36471058&oldid=2198940507"